Biologic treatments for rheumatoid arthritis

被引：0
|
作者：
Kotecha, Jalpa B. [1 ]
Kiely, Patrick D. W. [1 ,2 ]
机构：
[1] St Georges Univ Hosp NHS Fdn Trust, Rheumatol, London, England
[2] St Georges Univ London, London, England
来源：
TRENDS IN UROLOGY & MENS HEALTH | 2019年 / 10卷 / 05期
关键词：
AMERICAN-COLLEGE; 2-YEAR EFFICACY; NON-INFERIORITY; OPEN-LABEL; ADALIMUMAB; RECOMMENDATIONS; REMISSION; RITUXIMAB; MANAGEMENT; THERAPY;
D O I：
10.1002/tre.711
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Biologic disease-modifying antirheumatic drugs (bDMARDs) have made a significant difference to the lives of people with rheumatoid arthritis (RA), in particular those who do not respond to conventional drugs. In this article the authors review the place in therapy of bDMARDs for RA and consider a range of factors that could contribute to further improvements to patient otucomes.
引用
收藏
页码：13 / 17
页数：5
相关论文
共 50 条
  • [1] Biologic treatments for rheumatoid arthritis
    Berrington, Jenny
    [J]. INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2006, 10 (03) : 159 - 165
  • [2] Infectious complications of biologic treatments of rheumatoid arthritis
    Mohan, AK
    Coté, TR
    Siegel, JN
    Braun, MM
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 179 - 184
  • [3] Patient Preferences for Biologic Treatments in Rheumatoid Arthritis
    Nafees, Beenish
    Lloyd, Andrew
    Gaich, Carol L.
    Birt, Julie
    Hughes, Rodney A.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S213 - S213
  • [4] When to initiate and discontinue biologic treatments for rheumatoid arthritis?
    Chatzidionysiou, K.
    van Vollenhoven, R. F.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2011, 269 (06) : 614 - 625
  • [5] Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis
    Hauber, A. Brett
    Cross, James T.
    Yocum, David E.
    Johnson, F. Reed
    Yang, Jui-Chen
    Villaneuva, Isidro
    Katz, Patricia P.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S487 - S488
  • [6] CONSUMPTION OF BIOLOGIC TREATMENTS FOR RHEUMATOID ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Gomes de Freitas, P.
    Brito, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S196 - S196
  • [7] EFFICACY OF BIOLOGIC TREATMENTS IN EARLY ACTIVE RHEUMATOID ARTHRITIS: AN INDIRECT COMPARISON
    Sawyer, Laura
    Chang, Stacey
    Diamantopoulos, Alex
    Dejonckheere, Fred
    [J]. RHEUMATOLOGY, 2015, 54 : 80 - 80
  • [8] EFFICACY OF BIOLOGIC TREATMENTS IN EARLY ACTIVE RHEUMATOID ARTHRITIS: AN INDIRECT COMPARISON
    Sawyer, L.
    Chang, S.
    Diamantopoulos, A.
    Dejonckheere, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 950 - 950
  • [9] Lessons for the use of non-biologic anchor treatments for rheumatoid arthritis in the era of biologic therapies
    Jacobs, Johannes W. G.
    [J]. RHEUMATOLOGY, 2012, 51 : iv27 - iv33
  • [10] Efficacy of Biologic Treatments in Early Active Rheumatoid Arthritis: An Indirect Comparison.
    Sawyer, Laura
    Chang, Stacey
    Diamantopoulos, Alex
    Dejonckheere, Fred
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S672 - S673
12345